A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety andEfficacy of Inhaled Treprostinil in Patients with Pulmonary Hypertension due to Chronic ObstructivePulmonary Disease (PH-COPD)

Project: Research project

Project Details

Description

A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients with Pulmonary Hypertension due to Chronic Obstructive Pulmonary Disease (PH-COPD)
StatusActive
Effective start/end date12/1/2012/31/24

Funding

  • United Therapeutics Corporation

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.